These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28119480)
21. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Bauer B; Hartz AM; Miller DS Mol Pharmacol; 2007 Mar; 71(3):667-75. PubMed ID: 17132686 [TBL] [Abstract][Full Text] [Related]
22. Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats: evidence for the involvement of nuclear factor-kappaB, a nitrosative stress-sensitive transcription factor, in the regulation. Maeng HJ; Kim MH; Jin HE; Shin SM; Tsuruo T; Kim SG; Kim DD; Shim CK; Chung SJ Drug Metab Dispos; 2007 Nov; 35(11):1996-2005. PubMed ID: 17664251 [TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice. Uchida Y; Ohtsuki S; Kamiie J; Terasaki T J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers. Miller DW; Hinton M; Chen F Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715 [TBL] [Abstract][Full Text] [Related]
25. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. Hartz AM; Bauer B; Block ML; Hong JS; Miller DS FASEB J; 2008 Aug; 22(8):2723-33. PubMed ID: 18474546 [TBL] [Abstract][Full Text] [Related]
26. Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors. Katz S; Ernst O; Avni D; Athamna M; Philosoph A; Arana L; Ouro A; Hoeferlin LA; Meijler MM; Chalfant CE; Gómez-Muñoz A; Zor T Immunol Lett; 2016 Jan; 169():73-81. PubMed ID: 26656944 [TBL] [Abstract][Full Text] [Related]
27. BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol. Mahringer A; Fricker G Mol Pharm; 2010 Oct; 7(5):1835-47. PubMed ID: 20735085 [TBL] [Abstract][Full Text] [Related]
28. P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling. Harati R; Benech H; Villégier AS; Mabondzo A Mol Pharm; 2013 May; 10(5):1566-80. PubMed ID: 22998451 [TBL] [Abstract][Full Text] [Related]
30. Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Hartz AM; Bauer B; Fricker G; Miller DS Mol Pharmacol; 2004 Sep; 66(3):387-94. PubMed ID: 15322229 [TBL] [Abstract][Full Text] [Related]
31. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity. Hartz AM; Mahringer A; Miller DS; Bauer B J Cereb Blood Flow Metab; 2010 Oct; 30(10):1742-55. PubMed ID: 20216549 [TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier. Banks DB; Chan GN; Evans RA; Miller DS; Cannon RE J Cereb Blood Flow Metab; 2018 May; 38(5):857-868. PubMed ID: 28447863 [TBL] [Abstract][Full Text] [Related]
33. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates. Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093 [TBL] [Abstract][Full Text] [Related]
34. [Significant role of poloxamer in drug transport across blood-brain barrier]. Zhang W; Fang XL Yao Xue Xue Bao; 2008 Sep; 43(9):890-7. PubMed ID: 19048778 [TBL] [Abstract][Full Text] [Related]
35. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation. Lemmen J; Tozakidis IE; Bele P; Galla HJ Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159 [TBL] [Abstract][Full Text] [Related]
36. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525 [TBL] [Abstract][Full Text] [Related]
37. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Pettus BJ; Kitatani K; Chalfant CE; Taha TA; Kawamori T; Bielawski J; Obeid LM; Hannun YA Mol Pharmacol; 2005 Aug; 68(2):330-5. PubMed ID: 15900018 [TBL] [Abstract][Full Text] [Related]
38. Regulation of cell migration and inflammation by ceramide 1-phosphate. Presa N; Gomez-Larrauri A; Rivera IG; Ordoñez M; Trueba M; Gomez-Muñoz A Biochim Biophys Acta; 2016 May; 1861(5):402-9. PubMed ID: 26875839 [TBL] [Abstract][Full Text] [Related]
39. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495 [TBL] [Abstract][Full Text] [Related]
40. Glutamate-mediated upregulation of the multidrug resistance protein 2 in porcine and human brain capillaries. Luna-Munguia H; Salvamoser JD; Pascher B; Pieper T; Getzinger T; Kudernatsch M; Kluger G; Potschka H J Pharmacol Exp Ther; 2015 Feb; 352(2):368-78. PubMed ID: 25503388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]